|
|
|
|
|
25.07.25 - 19:15
|
StageZero Announces Delisting from the TSX and a Concomitant Application for Listing on the NEX Exchange (The Newswire)
|
|
TORONTO – TheNewswire - July 25, 2025 - StageZero Life Sciences, Ltd. (the “Company” or “StageZero”) (TSX: SZLS) announces that its public listing on the TSX will be terminated on August 14, 2025 and concomitantly it is applying to the NEX Exchange (“NEX”) to be publicly listed on NEX.
The NEX is a separate board of the TSX Venture Exchange. The NEX offers its listed companies support and visibility provided by a listing and trading environment tailored to their needs specifically while they are restructuring or financing prior to reactivating their full business. Upon reactivation, the Company has the option of applying to list on the TSX or the TSX Venture exchanges.
Moving to the NEX offers the following benefits to Shareholders and the Company:
Continued trading within the prestigious TMX Group of stock exchanges. Trading on NEX takes place on the same fully electronic system as TSX V and is governed by identical trading rules.
Streamlined filing obligations allowing mo...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21.05.25 - 23:51
|
XFRA: DIVIDEND/INTEREST INFORMATION - 23.05.2025 - EQUBF_01 (XETRA)
|
|
Das Instrument 9TX CA87262K1057 TMX GROUP LTD EQUITY wird cum Dividende/Zinsen gehandelt am 22.05.2025 und ex Dividende/Zinsen am 23.05.2025
The instrument 9TX CA87262K1057 TMX GROUP LTD EQUITY has its pre-dividend/interest day on 22.05.2025 and its ex-dividend/interest day on 23.05.2025...
|
|
|
|